DIA
EBS icon

Dana Investment Advisors’s Emergent Biosolutions EBS Stock Holding History

Dana Investment Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-92,305
Closed -$8.58M – 323
2021
Q1 		$8.58M Buy
92,305
+103
+0.1% +$10.5K 0.4% 73
2020
Q4 		$8.26M Buy
92,202
+13,898
+18% +$1.28M 0.41% 76
2020
Q3 		$8.09M Sell
78,304
-29,523
-27% -$3.18M 0.44% 74
2020
Q2 		$8.53M Sell
107,827
-20,164
-16% -$1.5M 0.46% 73
2020
Q1 		$7.41M Sell
127,991
-13,917
-10% -$802K 0.45% 67
2019
Q4 		$7.66M Sell
141,908
-33,150
-19% -$1.8M 0.37% 73
2019
Q3 		$9.15M Sell
175,058
-54,268
-24% -$2.53M 0.46% 71
2019
Q2 		$11.1M Sell
229,326
-38,579
-14% -$1.85M 0.55% 71
2019
Q1 		$13.5M Buy
267,905
+17,043
+7% +$1.01M 0.64% 61
2018
Q4 		$14.9M Buy
250,862
+143,023
+133% +$9.22M 0.76% 49
2018
Q3 		$7.1M Sell
107,839
-3,907
-3% -$228K 0.29% 85
2018
Q2 		$5.64M Sell
111,746
-12,574
-10% -$655K 0.25% 89
2018
Q1 		$6.54M Buy
+124,320
New +$6.2M 0.29% 82
2016
Q3 		– Sell
-44,966
Closed -$1.26M – 279
2016
Q2 		$1.26M Buy
44,966
+1,546
+4% +$60.6K 0.06% 201
2016
Q1 		$1.58M Buy
43,420
+41,621
+2,314% +$1.47M 0.07% 162
2015
Q4 		$1.8K Sell
1,799
-46,762
-96% -$1.63M 0.09% 141
2015
Q3 		$1.38M Sell
48,561
-10,138
-17% -$334K 0.07% 161
2015
Q2 		$1.93M Buy
58,699
+16,282
+38% +$505K 0.09% 135
2015
Q1 		$1.22M Sell
42,417
-1,227
-3% -$35.2K 0.06% 168
2014
Q4 		$1.19M Buy
43,644
+2,134
+5% +$50.9K 0.05% 161
2014
Q3 		$885K Buy
41,510
+5,998
+17% +$137K 0.05% 182
2014
Q2 		$798K Buy
+35,512
New +$827K 0.05% 202

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dana Investment Advisors's EBS Position: Q2 2021 in Review

Dana Investment Advisors sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 92,305 shares — an estimated $8.58M sold.

Dana Investment Advisors first reported a position in EBS in Q2 2014 and held it in 22 quarters. The position peaked at $14.9M in Q4 2018. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Dana Investment Advisors reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Dana Investment Advisors sold 92,305 Emergent Biosolutions shares in Q2 2021, an estimated $8.58M.
  • Dana Investment Advisors first reported a position in Emergent Biosolutions in Q2 2014 and held it in 22 quarters.
  • Dana Investment Advisors's Emergent Biosolutions position peaked at $14.9M in Q4 2018.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Dana Investment Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.